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Abstract According to the annual report of the World
Anti-Doping Agency, steroids are the most frequently
detected class of doping agents. Detecting the misuse of
endogenously occurring steroids, i.e. steroids such as
testosterone that are produced naturally by humans, is one
of the most challenging issues in doping control analysis.
The established thresholds for urinary concentrations or
concentration ratios such as the testosterone/epitestosterone
quotient are sometimes inconclusive owing to the large
biological variation in these parameters.
For more than 15 years, doping control laboratories
focused on the carbon isotope ratios of endogenous steroids
to distinguish between naturally elevated steroid profile
parameters and illicit administration of steroids. A variety
of different methods has been developed throughout the last
decade and the number of different steroids under investi-
gation by isotope ratio mass spectrometry has recently
grown considerably. Besides norandrosterone, boldenone
was found to occur endogenously in rare cases and the
misuse of corticosteroids or epitestosterone can now be
detected with the aid of carbon isotope ratios as well. In
addition, steroids excreted as sulfoconjugates were investi-
gated, and the first results regarding hydrogen isotope ratios
recently became available.
All of these will be presented in detail within this review
together with some considerations on validation issues and
on identification of parameters influencing steroidal isotope
ratios in urine.
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Introduction
Steroids are still very popular amongst athletes as performance-
enhancement drugs and are responsible, according to the
annual World Anti-Doping Agency (WADA) laboratory
statistics report [1], for nearly two thirds of all adverse or
atypical analytical findings. In the WADA list of prohibited
substances, anabolic androgenic steroids are divided into
exogenous and endogenous compounds [2]. In the case of
exogenous steroids, i.e. steroids not synthesized by humans,
the presence of these substances or their metabolites is strictly
prohibited in urine specimens. Detection at any concentration
results in an adverse analytical finding.
For endogenous steroids, i.e. steroids produced naturally
by humans, the situation is more complicated as these steroids
are always present in doping control specimens. Therefore,
thresholds have been established for the concentration or
concentration ratio. A very useful one is the ratio of
testosterone (T) to epitestosterone (EpiT) (T/EpiT), both
excreted as glucuronides into urine [2–5]. A T/EpiT ratio
exceeding the threshold of 4 is suspicious for T administra-
tion as defined in the WADA Technical Documents.
Unfortunately, in most samples in which this threshold is
exceeded, the T/EpiT ratios are elevated owing to natural
variations [4]. To distinguish between these natural elevated
T/EpiT ratios and steroid misuse, longitudinal steroid profiles
were established and are still used today [5–7]. As these are
quite time-consuming and expensive, doping control labora-
tories started to discover, in the mid-1990s, the potential of
gas chromatography/combustion/isotope ratio mass spec-
trometry (GC/C/IRMS) to assist in making a more timely
decision [8–13].
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Isotopic fractionation takes place during the formation or
degradation of organic substances. The stable isotopes of
carbon, 13C and 12C, are then not uniformly distributed
throughout all organic materials [14, 15]. Consequently,
steroids produced inside the body exhibit a different 13C/12C
ratio than pharmaceutically produced steroids. The carbon
isotope ratios (CIR) of endogenous steroids reflect the
individual’s diet (see “Factors influencing CIR of endoge-
nous steroids”) derived from a mixture of C3 and C4 plants.
Pharmaceutically produced T, in contrast, is obtained from
one plant material, namely the C4 plant soy, and therefore in
most cases shows depleted 13C/12C ratios.
CIR are expressed as δ13C values against the interna-
tional standard Vienna Pee Dee Belemnite (VPDB) based
on the equation
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where 13C/12C refers to the isotopic composition of the
sample or standard [16].
Usually, δ13C values of endogenous steroids fall between
−26‰ and −16‰, whereas pharmaceutical preparations have
δ13C values below −27‰ [17–19]. As the absolute differ-
ence between endogenous and exogenous steroids can be
quite small, WADA established difference (Δ) values
between endogenous reference compounds (ERC) and target
compounds (TC) to distinguish the source of urinary steroids.
These Δ values are expressed by Eq. 2:
TCERC CC
1313‰ ð2Þ
All ERC and TC routinely employed in doping control
analysis are depicted in Fig. 1, showing the assumed
metabolic pathways, and are listed in Table 1. All endoge-
nous steroids and their abbreviations used throughout this
article are also summarized in Table 1.
This review is subdivided into several parts dealing with
different aspects of isotope ratio mass spectrometry (IRMS)
and steroids. It starts with a brief review of the develop-
Fig. 1 Metabolism of endogenous steroids. Steroids with abbreviated
names in blue are referred to as precursor steroids, steroids with
abbreviated names in green are used as endogenous reference
compounds and steroids with abbreviated names in red are target
compounds. Brown steroids depict the metabolic route yielding DCM.
All abbreviations are described in Table 1
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ments in IRMS techniques, then summarizes the recent
developments in methods for doping analysis using 13C/12C
isotope ratios, leading to the topic of 2H/1H determinations
of endogenous steroids. Then factors influencing the CIR of
urinary steroids are discussed together with new approaches
in validation protocols utilized for GC/C/IRMS.
The development of IRMS and its introduction to sports
drug testing
The development of IRMS from its beginning in the 1930s until
today has been reviewed several times [20]. To meet the
requirements for routine isotope ratio measurements of
steroids, gas chromatography (GC) systems had to be coupled
to IRMS systems. With this technique, developed in the
1970s, it was possible to measure nanogram amounts of
carbon [21–24]. The key feature was the online combustion of
organic compounds that were eluted from the GC system
together with the direct transfer of the CO2 formed, after water
removal, into the mass spectrometer [25–28]. Since then some
reasonable hardware improvements have been accomplished
[29–33] together with software advancements [34–36].
One of the main problems regarding steroid measure-
ments was the low volatility and the relative high polarity
of these compounds. To overcome peak broadening and
tailing in the GC system, derivatisation of steroids is
usually employed. Initially, the derivatisation of the
hydroxyl function to trimethysilyl ethers (TMS) was the
method of choice [37]. Later, the enolization and trime-
Abbreviation Trivial name IUPAC name
CHOL Cholesterol Cholest-5-en-3β-ol
PREG Pregnenolone 3β-Hydroxy-5-pregnen-20-one
PROG Progesterone Preg-4-ene-3,20-dione
17a-OH-PREG Hydroxypregnenolone 3β,17α-Dihydroxy-pregn-5-en-20-one
17a-OH-PROG Hydroxyprogesterone 17-Hydroxy-pregn-4-ene-3,20-dione
16EN Androstenol 5α-Androst-16-en-3α-ol
5bPT Pregnanetriol 5β-Pregnane-3α,17α,20α-triol
PT Pregnenetriol Pregn-5-ene-3β,17,20α-triol
PD Pregnanediol 5β-Pregnane-3α,20α-diol
3aP 3-Hydroxypregnone 3α-Hydroxy-5β-pregnan-20-one
OHA 11-Hydroxyandrosterone 3α,11β-Dihydroxy-5α-androstan-17-one
OHE 11-Hydroxyetiocholanolone 3α,11β-Dihydroxy-5β-androstan-17-one
11KETO 11-Ketoetiocholanolone 3α-Hydroxy-5β-androstane-11,17-dione
DHEA Dehydroepiandrosterone 3β-Hydroxy-androst-5-en-17-one
DHEA_S Dehydroepiandrosterone sulfate 3β-Hydroxy-androst-5-en-17-one 3-sulfate
ADION Androstenedione Androst-4-ene-3,17-dione
EpiT Epitestosterone 17α-Hydroxy-androst-4-en-3-one
5EN17a 17α-Androstenediol Androst-5-ene-3β,17α-diol
5EN17b 17β-Androstenediol Androst-5-ene-3β,17β-diol
T Testosterone 17β-Hydroxy-androst-4-en-3-one
DHT Dihydrotestosterone 17β-Hydroxy-5α-androstan-3-one
DCM Cyclometabolite 3α,5-cyclo-5α-Androstan-6β-ol-17-one
5aEpiD 5α-Epiandrostanediol 5α-Androstane-3α,17α-diol
5bEpiD 5β-Epiandrostanediol 5β-Androstane-3α,17α-diol
5a 5α-Androstanediol 5α-Androstane-3α,17β-diol
5b 5β-Androstanediol 5β-Androstane-3α,17β-diol
E Etiocholanolone 3α-Hydroxy-5β-androstan-17-one
A Androsterone 3α-Hydroxy-5α-androstan-17-one
THC Tetrahydrocortisone 3α,17,21-Trihydroxypregnane-11,20-dione
THF Tetrahydrocortisol 3α,11β,17,21-Tetrahydroxypregnan-20-one
NORA Norandrosterone 3α-Hydroxy-5α-estran-17-one
BO Boldenone 17β-Hydroxy-androsta–1,4–dien–3–one
BM1 Boldenone-metabolite 1 17β-Hydroxy-5β-androst-1-en-3-one
F Formestane 4-Hydroxy-androst-4-ene-3,17-dione
Table 1 Overview of all
endogenous steroids, their
abbreviations used in this article
together with their IUPAC
names
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thylsilylation of oxo functions was accomplished by the use
of trimethyliodosilane formed in situ [5, 38]. This method
was used for cholesterol (CHOL) determinations early in
development, but this derivatisation method proved to be
useless for IRMS determinations as the layer of combusted
silicon caused problems within the online combustion tubes
by retaining carbon and influencing the δ13C values of the
CO2 formed [39, 40].
Acetylation of hydroxyl functions with acetic anhydride
and pyridine prior to CIR determination became the most
common derivatisation procedure for steroids. The different
methods of sample preparation will be summarized in the
following section.
Since the late 1990s, it has been possible to measure
hydrogen isotope ratios (HIR) with a continuous-flow
IRMS system [41–44]. Hydrogen constitutes, besides
carbon, the other abundant element in the steroid backbone
and might become of interest for sports drug testing.
The latest instrumental improvement, which is now
becoming more and more commercially available, was the
direct coupling of a GC system to both an IRMS system
and a mass-selective detector (MSD) to achieve a simulta-
neous determination of isotope ratios with mass spectral
data [45]. Although this application is needed for identifi-
cation of target analytes or coeluted substances, it reduces
the amount of sample available for IRMS. This could cause
problems in measurement of substances with low concentra-
tion of interest in doping controls such as norandrosterone
(NORA) and boldenone (BO).
IRMS methods developed and used in sports drug
testing
The main class of substances investigated with IRMS in the
context of doping control analysis is the steroids. In this
section, a chronological overview of developments is given.
The first offline IRMS determinations, i.e. using a dual-
inlet instrument and a sample preparation method encompass-
ing offline combustion, of human serum CHOL took place in
the early 1980s [46, 47]. In 1993, several research results
were published on the topic of CHOL absorption and
metabolism. These included 2H- and 13C-labelled CHOL
together with acetylation and MSD determination [48], and
offline IRMS determination of the 13C-labelled compound
after high-performance liquid chromatography (HPLC)
separation on an octadecyl silica column [49]. GC/C/IRMS
was also introduced to steroid measurement of plasma
CHOL after solid-phase extraction (SPE) on an amino
(NH2) column and TMS derivatisation [39].
From 1994 onwards, many sample preparation methods
for urinary steroids were developed. The main task of
sample preparation is the purification of target analytes
from the complex biological matrix (urine) to achieve
efficiently isolated and purified compounds and to avoid
coelutions that might impede IRMS determinations.
The first published method allowing for determination of
CHOL, T, dehydroepiandrosterone (DHEA) and 5β-
androstanediol (5b), by Becchi et al. [8], encompasses
liquid–liquid extraction (LLE) of unconjugated CHOL
followed by SPE and hydrolysis of glucuronidated steroids
with β-glucuronidase. The unconjugated steroids were then
further purified by HPLC on a C18 column using an
acetonitrile and water mobile phase and afterwards they
were acetylated prior to measurement. The main features of
this sample preparation, LLE and SPE, were retained in all
subsequent methods. Aguilera et al. [9] presented a method
with acetylation prior to HPLC offering the chance to
determine 17β-androstenediol (5EN17b). The purification
of T using immunoaffinity chromatography was investigated
but not employed further [10, 11]. Shackleton et al. [12, 13]
then broadened the range of steroids investigated [5α-
androstanediol (5a), 5b, 5α-epiandrostanediol (5aEpiD),
5β-epiandrostanediol (5bEpiD) and 5EN17b] by hydrolysis
of both glucuronides and sulfoconjugates and by performing
the SPE on a Sephadex LH-20 column after removal of
ketonic steroids using Girards reagent T.
In 1999 a method was published focusing on pregnane-
diol (PD), 5a and 5b, especially to improve the detection of
T misuse [50]. Derivatisation with O-ethylhydroxylamine
was investigated for determination of etiocholanolone (E)
and androsterone (A) [51], and Ueki and Okano [17]
investigated PD, 5a and 5b excreted glucuronidated and
added dehydroepiandrosterone sulfate (DHEA_S) to the
scope of IRMS methods using a TEAP-LH20 anion
exchange column.
In 2000, another method for E and A was published
but lacked the possibility of determining an ERC [52]
and the first experiments regarding pregnenolone (PREG)
administration were completed [53]. PREG may be used
by athletes as a masking agent, i.e. a substance with no
performance-enhancing properties but the ability to cam-
ouflage other steroid misuse. PREG is largely converted to
PD and therefore can change the CIR of this often used
ERC and lead to false-negative results. Furthermore, the
misuse of cortisone and its detection by CIR were
investigated using the main metabolites tetrahydrocortisol
(THF) and tetrahydrocortisone (THC) after both had been
converted by potassium dichromate oxidation to 5β-
androstan-3,11,17-trione [54].
The first reference population (RefPop)-based values (n=73
males) for 5a, 5b and PD were reported 1 year later [55] and
a new analyte, EpiT, was added to the scope of IRMS
methods [56]. EpiT has the potential of a masking agent not
by influencing CIR but by lowering the T/EpiT ratio of an
athlete whereby a administration of T might remain undis-
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covered. The first method encompassing androstenol (16EN)
together with PD, E, A, 5a and 5b was reported in 2004 and
was tested using excretion studies undertaken with DHEA,
PREG and T [57, 58]. A novel steroid, the DHEA cyclo-
metabolite (DCM), was also included in an existing method
for E, A and 11-ketoetiocholanolone (11KETO) [59].
The first results on the 2H/1H ratios of E and A were
reported [60] as well as some T-related preparations
exhibiting endogenous CIR [61]. One year later, RefPop-
based values for E, A and 11KETO (n=167 athletes) were
published together with a first insight into isotopic
fractionation during DHEA metabolism [62]. After multiple
oral administration of DHEA, the urinary excreted main
metabolite E showed more deplete δ13C values than the
administered DHEA, suggesting that isotopic fractionation
must have taken place during the metabolic transformation.
In the meantime, investigations on PREG were ongoing
[63] and a new method using hydropyrolysis of CHOL
instead of derivatisation was developed [64].
In 2006 a new analyte, NORA, was investigated by
IRMS, as this occurred in some rare cases endogenously or
is produced during bacterial degradation in urine. A CIR
method was needed to distinguish these cases from those
arising from administration of nandrolone or related
prohormones. Sample preparation was extended to a
twofold HPLC clean-up using two different columns [65].
The first investigations on the influence of diet on CIR of
endogenous steroids were published at that time [66, 67]
together with research on interindividual variability of CIR
after T administration [68]. In the same year, routine doping
control samples (n=99) showing elevated DHEA concen-
trations (between 100 and 200 ng/mL) were investigated by
IRMS and the mean Δ values for 11-hydroxyandrosterone
(OHA), A and E were presented [69]. Ninety-eight samples
showed clearly endogenous values, questioning the estab-
lished WADA threshold for glucuronidated DHEA of
100 ng/mL.
Formestane (F), which is produced endogenously in low
amounts, was added to the steroids of interest for IRMS in
2008 [70] to distinguish low-level natural substance from
administered drug. It has to be considered that not only F
intake itself will result in influenced CIR of urinary F.
Administration of androstenedione (ADION) also has a
strong influence on CIR of urinary F. In addition,
considering the different punishments applied if their use
is detected in sports drug testing, the distinction between
both types of administration with the help of CIR
measurement is important.
The Cologne group reported the results of two RefPops,
one on E, A, OHA and PD (n=56) to show differences in δ
values between the genders [71] and one encompassing E,
A, 5a, 5b, T, EpiT, DHEA, OHA, PD and 16EN with n=61
volunteers allowing for a comprehensive consideration of
reference-based limits for Δ values and isotopic differences
between urinary excreted steroids due to isotopic fraction-
ation during metabolism [72].
A comparison of sample preparation including HPLC
clean-up of samples rather than to rely only on SPE clean-
up was reported in 2009 [73]. In that year a research project
focusing on the influence of diet on CIR of steroids was
published [74] and another RefPop encompassing 171 male
soccer players emerged [75]. Two laboratories reported data
using collected samples, which were investigated for CIR
and which gave a significant difference in δ values between
athletes from different countries but which showed that the
Δ values were not influenced [19, 76]. Investigations on
the misuse of 4-androstene-3,11,17-trione, a nutritional
supplement [77], and a comprehensive method to detect
cortisone misuse, again using oxidation of target analytes,
were published [78]. Another research focus was on EpiT
and its metabolites 5aEpiD and 5bEpiD, which provided
data for another RefPop (n=74), again showing differences
between the genders in their CIR [79], and the first
extensive results on the 2H/1H ratio of endogenous urinary
steroids were reported [80]. As expected, HIR showed a
larger variation in their δ2H values, but the associated Δ
values were found to be stable; this might become a
promising approach for doping control.
In 2010, results on 2H/1H ratios of synthetic T prepara-
tions became available [81]. A method to detect the
endogenous source of BO by measuring the CIR of urinary
BO and boldenone-metabolite 1 (BM1) [82] and the first
investigations on urinary steroids excreted as sulfoconjugates
[namely E, A, epiandrosterone EpiA, 17α-androstenediol
(5EN17a), 5EN17b, pregnenetriol (PT)] together with
reference values were published [83]. Furthermore, IRMS
values of steroid degradation products such as 5α-androstan-
3,17-dione and 5β-androstan-3,17-dione were investigated,
showing strong isotopic fractionation especially during the
formation of DCM by deconjugation of DHEA_S [84].
Finally, two reviews on IRMS in doping analysis have been
published [85, 86].
2H/1H ratios of endogenous urinary steroids
Why should 2H/1H ratios be used in doping control
analysis?
As discussed in the previous section, until now the use of
CIR has been well investigated. Unfortunately, some
specific problems became apparent regarding the use of
CIR alone. As can be seen in Fig. 2, the difference between
endogenous and synthetic steroids is not always large
enough to allow them to be distinguished. Whereas
endogenous steroids reflect the CIR of a mixture of C3
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and C4 plants, synthetic steroids should exhibit a clear
single C3 signature, resulting in values lower than −26.5‰
[17, 18]. Some rare cases have been reported with steroids
exhibiting δ13C values in the endogenous range [61, 82]
and recently a comprehensive investigation on seized T
samples showed that nearly 10% of all T preparations were
enriched more than −25‰ [81]. To overcome these
problems, which could result in false-negative doping
control samples, HIR might offer a powerful solution.
Isotopic fractionation of hydrogen in plants does not follow
a route as distinctive as for carbon and it results in the larger
variability of HIR [87–90]. Furthermore, the main factor
influencing the 2H/1H ratio of endogenous steroids should be
drinking water, showing a large variability, and not food
intake [91, 92]. Thus, the HIR should be independent of the
CIR, allowing for the detection of exogenous steroids in cases
where CIR alone might fail for the above-mentioned reasons.
Technical considerations
HIR are expressed in parallel to CIR using Eq. 3 with
Vienna Standard Mean Ocean Water (VSMOW) as an
international reference:
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Δ values are calculated as for CIR (Eq. 2).
As the natural abundance of 2H is far less than that of
13C (see Table 2), the amount needed for a valid HIR
determination is approximately tenfold that for a valid CIR
determination and the results have larger standard devia-
tions (SD) [28]. In addition to the higher amount of sample
necessary, the combustion differs considerably from that for
CIR. High-temperature pyrolysis was found to be the most
effective way to produce H2 gas from organic compounds
eluted from the GC column [41, 42].
During the IRMS measurements the low-energy helium
used as a carrier gas in the system causes problems as it
corrupts them/z 3 measurements [93]. This problem has been
overcome by incorporation of a retardation lens for filtering
all helium interferences and which is now employed in the
commercially available IRMS systems [44]. In correlation to
the partial pressure of H2 entering the ion source, H3
+ is
formed and adulterates the HIR determination. This formation
of H3
+ is another interference for m/z 3, which is amount-
dependent and has to be corrected for [94–96]. Furthermore,
the helium flow through the combustion tube and the issue of
preconditioning the tube with a carbon layer have to be
considered [28, 97]. The phenomenon of preconditioning
stabilizing the HIR determined can be attributed to a shift
of the equilibrium from intact molecules composed of
carbon and hydrogen (such as methane and propane)
towards H2 in the presence of solid carbon acting as a
catalyst at elevated temperatures [80, 98].
First results on endogenous HIR
The first investigation on HIR of steroids was on plant sterols
showing δ2H values ranging from −200‰ to −300‰ [88]. In
2004, the first attempt was made to determine the HIR of
urinary steroids measured underivatised in order to investi-
gate its applicability to antidoping analysis [60]. These
results were promising but complicated by memory effects
during isotope ratio measurements. To overcome these
problems and to extend the number of steroids to be analysed,
different derivatisation procedures were investigated.
The first trial using steroid heptafluorbutyrates was
promising with regard to both HPLC clean-up and the first
IRMS measurements. It enabled the determination of
11KETO, OHA, 16EN, PD, E, A, 5a and 5b from one
urine specimen and as this derivatisation did not add any
hydrogen to the steroid backbone, it rendered any correc-
tion for the derivatisation moiety unnecessary. Memory
-30 -18 ‰-28 -26 -24 -22 -20
synthetic steroids
endogenous steroids
-30 -20 -10 0 ‰
C3-plants C4-plants
CO2
Fig. 2 Overview of δ13C values expected for endogenous and
synthetic steroids. Further information can be found in the text
Element Isotope Natural
abundance
1‰ change Typical
precision (‰)
Typical
sensitivity (nmol)
Hydrogen 1H 0.999844 0.000000156 2–5 10–50
2H 0.000156
Carbon 12C 0.98889 0.00001123 0.1–0.3 0.1–5
13C 0.01111
Table 2 Isotopic abundance at
natural levels [28, 92]
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effects were also found for this method, but could be easily
corrected for by using 3β-hydroxy-5α-androstan e (RSTD)
as secondary reference standard with each measurement.
The benefit of this correction is depicted in Fig. 3,
decreasing the SD for standard determinations from more
than ±16‰ to below ±8‰. Replicated sample preparation
and measurement of a blank urine showed comparable
results after correction was applied (Table 3). Unfortunate-
ly, fluorine was found to be an inadequate derivatisation
agent, with HF emerging from the ion source after short
time despite the use of copper wires for removal of HF
from the gas stream, destroying the ceramic thermal
conversion tube and causing additional memory effects by
the formation of HF during combustion [28, 99].
Despite addition of hydrogen to the analyte, acetylation
was found to be a reasonable derivatisation process. Using
this it was possible to determine the HIR of ten different
urinary steroids (OHA, PD, 16EN, E, A, 5a, 5b, T, EpiT,
DHEA) from a single aliquot of urine [80]. An interesting
correlation between the added reference standard and the
target analyte could be observed, not only reflecting
problems caused by “classical” memory effects. However,
owing to the stability and reproducibility of this correlation,
the values obtained could easily be corrected for.
The preliminary RefPop investigated (n=18 males)
showed the presumed stability of interindividual Δ2H
values and this should, after further investigation of an
appropriate larger population, allow for the calculation of
reference values as has been accomplished for CIR.
Moreover, a good correlation between CIR and HIR of
endogenous steroids could be found, enabling consideration
of metabolic pathways and subsequent isotopic fraction-
ation. The results suggested a different isotope ratio for
both carbon and hydrogen in the different steroid produc-
tion sites in the human body [80].
Conclusions
These first results on HIR look promising for use in sports
drug testing and should offer the opportunity to use HIR in
addition to or complementary to CIR. The results published
on the isotope ratios of seized T preparations promote this
promise to only a limited extent [81]. Preparations of T
found with CIR in the endogenous range (above −26‰) did
not exhibit significantly different HIR from the those
determined for endogenous T. Further research will have
to be conducted on this topic to evaluate the prospects for
use of HIR in doping control analysis.
Factors influencing CIR of endogenous steroids
The different RefPops investigated so far allow for
identification of some of the factors influencing the isotopic
composition of urinary excreted steroids. Some are widely
accepted as derived from the influence of diet and some are
still under discussion as arising from the influence of
ethnicity on δ13C values. All possible factors identified will
be discussed.
Influence of diet
Subsequent to the findings for different isotopic composi-
tions in different varieties of plants, the influence of the diet
on the 13C/12C ratio found in animals was investigated [87,
100–102]. Basically, animals reflect the CIR of their diet,
usually showing slightly enriched values, which resulted in
the dictum by DeNiro and Epstein: “You are what you eat
(plus a few ‰)”.
Shortly after, results on humans were reported, showing
the correlation of CIR to diet and hair together with
Fig. 3 Hydrogen isotope ratios of 25 consecutive determinations of a
standard mixture containing (RSTD) (squares), 16EN (diamonds) and
E (triangles). The raw data are depicted on the left, and the values
corrected for by RSTD are depicted on the right. Further information
can be found in the text
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geographical variations in δ13C values of diet [103]. It took
quite a long time until the relationship between diet and
CIR of steroids was investigated. Some first results on this
topic were reported in 2005, showing that an isotopic
switch in diet results in a change of δ13C values of steroids
[67]. The same was found for three top-level athletes living
partly in Switzerland and in an African country. After the
diet had been changed, δ13C values could be made to differ
by more than 2‰ [68]. Comparable results were obtained
for two German women visiting the USA for 2 weeks. Even
after this short trip, their δ13C values were enriched by
approximately 1‰ [72], reflecting a change to a diet rich in
corn-derived products.
In 2009, the influence of geographical variation on the
CIR of steroids was reported by two groups [19, 76].
Presumably, the reasons for these variations are due to the
different eating habits together with the differing isotopic
composition of food in various parts of the world [103].
Depleted CIR of steroids of a group of vegetarians mainly
eating soy products have also been reported [74].
Overall, the influence of diet on the CIR of urinary
steroids seems not to be problematic for doping control.
The influence on Δ values, i.e. the differences between
ERC and TC, can be assumed to be negligible as both ERC
and TC are affected in parallel. Thresholds established for
Δ values therefore are independent of the absolute δ13C
value [19, 76]. Short-term variations might have an
influence if one steroid is influenced faster than another
by the change in diet. The preliminary results presented on
this topic did not show a false-positive case induced by a
change in diet [67, 68, 72].
Influence of gender
All of the early RefPops investigated in the context of
doping control consisted only of males or undeclared
gender. The first investigations on the impact of gender
on CIR of urinary steroids were presented by Flenker et al.
[71]. Women tend to show more depleted, i.e. more
negative, δ13C values in their urinary steroids OHA and
A. This finding was supported by data from routine doping
control samples and another RefPop investigated [19, 79].
PD showed the same pattern, whereas EpiT, investigated in
the latter population [79], was not significantly different for
males and females, but its metabolites 5aEpiD and 5bEpiD
were. Steroids excreted as sulfates demonstrated the same
trend towards more depleted values for females, but only
DHEA and 5EN17a were found to be significant [83].
A closer look at the data revealed that the difference
could not be attributed to gender but rather could be
attributed to the use of oral contraceptives [71, 79]. Only
those women using contraceptives showed significantly
different CIR in several endogenous steroids (Fig. 4).
Women not using contraceptives showed the same CIR as
men in their urinary steroids. Despite the fact that the
influence of oral contraception on the steroid profile of
women is known and has been well investigated [5, 104], it
is not easy to explain the differences found in CIR. Usually
a decrease in the amount of some steroids excreted can be
found. But the concentration of steroids excreted is usually
not correlated to the corresponding δ13C values [72, 79].
One possible explanation may be the influence of admin-
istered contraceptives on the different enzymatic reactions
taking place inside the body, transforming steroids. This
could change the isotopic fractionation induced by particular
enzymes and result in different CIR of the urinary excreted
steroids.
Another explanation may be a difference in CIR of
steroids excreted at different production sites, namely the
adrenal gland and the gonads. A third possible production
site in women is the corpus luteum, producing high
amounts of PREG depending on the status of the menstrual
cycle. PREG is mainly converted to PD and to other
steroids with a 5α configuration. This production is
completely suppressed by oral contraceptives. To investi-
gate a possible difference in CIR of steroids produced by
the corpus luteum which might explain the differences
found in CIR of women using or not using contraceptives,
two women (one using oral contraceptives and the other
not) collected urine samples over one menstrual cycle and
the urinary concentrations were measured as well as the
CIR of selected steroids. The results obtained are depicted
in Fig. 5.
The female volunteer not using oral contraceptives
showed the expected increase in urinary concentrations of
PD in the luteal phase of the menstrual cycle. The PROG
formed by the corpus luteum is primarily metabolized to
PD (see Fig. 1) and is renally excreted. The PD concen-
Table 3 Hydrogen isotope ratios of endogenous steroids, n=8 consecutive preparations of one male blank urine sample. All values in
δ2HVSMOW (‰)
11KETO (‰) OHA (‰) 16EN (‰) PD (‰) A (‰) E (‰) 5a (‰) 5b (‰)
Mean −290 −285 −255 −238 −274 −289 −252 −288
SD 2.9 4.9 8.2 5.3 5.0 5.2 7.4 4.3
SD standard deviation
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trations excreted by the woman using contraceptives
remained stable over the complete cycle. The δ13C values
remained stable in both volunteers, only showing a slight
trend towards more depleted values with an increasing
amount of PD excreted. This trend cannot explain the
differences found between women not using contraceptives
and women using contraceptives. It is too small and is in
the opposite direction. Presumably, this belongs to an effect
already described in the context of excretion studies where
an elevated amount of urinary excreted steroids caused a
slight depletion of the CIR in these steroids [79].
Therefore, further studies are necessary to elucidate the
difference in CIR found for women using oral contraceptives.
Influence of steroid metabolism
Many different enzymes are involved in the metabolism of
steroids. Detailed overviews can be found in the literature
[105–109]. Some of these enzymes are ubiquitous, some
are only found in distinctive compartments of the body.
Overall, this results in a very complicated reaction network,
partly depicted in Fig. 1, starting from CHOL and ending
up in numerous different steroids excreted into urine, faeces
and sweat.
Every diffusion process, every enzymatic or chemical
reaction can be accompanied by isotopic fractionation [14,
15]. Little is known about the induced changes of isotope
ratios of steroids during these processes.
In 2005, a comprehensive study on DHEA administration
was performed, showing that one of the excreted main
metabolites of DHEA, E, was found depleted in comparison
with the administered steroid and the other main metabolite, A
[62]. In addition, more E is excreted than A. Presumably the
5-ene-steroid DHEA is metabolized to the 5β-steroid E to a
higher extend than to the 5α steroid A and especially the 5β-
Fig. 5 Changes in urinary concentrations and CIR of PD over the
menstrual cycle of one woman using oral contraceptives (fw) and one
woman not using oral contraceptives (f). Circles represent the CIR of
PD of the woman using oral contraceptives, diamonds represent the
CIR of PD of the woman not using oral contraceptives, black triangles
represent the concentration of PD of the woman not using oral
contraceptives and open triangles represent the concentration of PD of
the woman using oral contraceptives. Further information can be
found in the text
Fig. 4 Box plots of carbon
isotope ratios (CIR) of different
endogenous steroids excreted as
glucuronides. fw women using
oral contraceptives (n=18),
f women not using oral
contraceptives (n=8). The
results found for women not
using oral contraceptives are the
same as those found for men
(n=48) [79]. * p<0.05,
**p<0.01 (Wilcoxon test).
Because E and A are coeluted
on the gas chromatography
column, the values are presented
as a sum
Recent developments in the use of isotope ratio mass spectrometry 441
reductase involved seems to involve isotopic discrimination,
resulting in the significant depletion of E [83].
Another excretion study with DHEA showed that the
underlying isotopic fractionation does not only depend on a
difference between 5α-reductase and 5β-reductase (Fig. 6)
[83]. In Fig. 6 the δ13C values of E, A, 5a and 5b excreted
as glucuronides after a single dose of 100 mg DHEA
administered orally are
depicted. The interconversion of 5-ene steroids such as
DHEA or 4-ene steroids such as T to the reduced 5α-
androstanes (5a, A) and 5β-androstanes (5b, E) is
irreversible. Usually it is assumed that 5a is the
intermediate in the metabolism to the end product A
and 5b is an intermediate on the way to E [69, 74, 105,
107]. A closer look at the results in Fig. 6 reveals a more
complicated situation inside the human body. For the 5α
steroids, the intermediate 5a is strongly influenced at the
beginning and then declines, whereas A is less strongly
depleted and then returns to starting values always
showing less depleted values. This finding is not contra-
dictory to the model with 5a being the intermediate of A
formation, as long as the pool of 5a inside the body is
small in comparison with that of A, which indeed can be
presumed. The different pool size might explain the
stronger depletion found for 5a, together with the fact that
the enzyme 5α-reductase is found in many different
tissues inside the body, rapidly interconverting the
administered DHEA and eliminating it through renal
excretion.
The outcome of the 5β steroids is completely different.
Only the main metabolite E is strongly depleted beyond the
δ13C value of the administered DHEA, whereas the
presumed intermediate 5b only shows a weak and slow
influence. Thus, 5b cannot be the only intermediate on the
metabolic way to E and 5β-reductase does not seem to be
solely responsible for the observed isotopic depletion of E
in contrast to DHEA. Otherwise this should be visible for
5b as well. A presumed direct way from DHEA to E is
along the route including 5EN17b (Fig. 1), circumventing
the formation of 5b. Another hint for the transformation
along this route is the relatively depleted CIR of 5EN17b
excreted sulfated after application of DHEA [83].
Complications arise when the results of HIR are taken
into account [80]. In Fig. 7, the HIR and CIR for E, A, 5a,
5b and DHEA of a RefPop encompassing 18 males are
plotted against each other. Again, the assumption of a
simple relationship between 5α and 5β steroids is not
supported by the data. Overall, A shows the most enriched
values in both HIR and CIR, whereas 5a shows the most
depleted ones and DHEA shows values close to those of A.
This does not fit with a direct and singular transformation
from DHEA via 5a to A. In the case of 5β steroids, 5b
shows values close to those of DHEA, whereas E is slightly
more depleted. Here a metabolism of DHEA via 5b to E
could be assumed.
As mentioned in the previous subsection, compartmen-
talization is a constitutive feature of steroid metabolism.
Steroids are mainly produced in the gonads and in the
adrenal gland, which again is subdivided into three parts
(zona fasciculata, zona reticularis and zona glumerulosa). If
we hypothesize that different production sites may produce
different isotopic ratios for the steroids formed, this could
explain the contradictory results for the DHEA excretion
studies. The steady state of steroid flux through the body is
strongly disturbed by oral administration of large amounts
of steroid. The renal excretion of steroids after oral
administration reflects the metabolism in the liver (first path
effect), which can explain the differences found between 5α
and 5β steroids in a RefPop (undisturbed) and the disturbed
steady state after administration. This could recently be
demonstrated by a PREG excretion study [110]. After oral
ingestion of 100 mg PREG, considerable amounts of PD and
Fig. 6 δ13C values of 5b (grey squares, dashed grey line), 5a (grey
triangles, solid grey line), A (open triangles, solid black line) and E
(open squares, dashed black line) after oral administration of 100 mg
DHEA at 0 h
Fig. 7 δ2H values against the δ13C values of a reference population
(RefPop) of n=18 males [80]. Open triangle A, circle DHEA, grey
square 5b, open square E, grey triangle 5a. The error bars represent
one standard deviation
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3-hydroxypregnone (3aP), both metabolites of PREG, were
found sulfo-conjugated in urine. Usually, both metabolites
are mainly excreted as glucuronides. The normal (undis-
turbed) pathway of excretion was disordered, leading to this
unusual sulfo-conjugated excretion.
In Fig. 8 the remaining steroids from the above-mentioned
RefPop with n=18 males are depicted [80]. Most of the EpiT
is produced in the testes and therefore should reflect the
values of this production site. T and 5a are, in addition,
derived from adrenal gland and peripheral metabolism, which
may explain their shift to more enriched CIR. Corticosteroids
such as OHA and 11KETO are only produced in the adrenal
gland and reflect the enriched CIR of this production site.
Another possible hint for differences in the CIR of production
sites may be the significant difference in CIR of DHEA
excreted as glucuronide and as the sulfoconjugate (Fig. 9).
Again DHEA_S, derived from the adrenal gland, shows more
enriched CIR than glucuronidated DHEA, derived from both
DHEA_S and androgen metabolism.
HIR seem to reflect the ongoing progress of steroid
metabolism. Metabolites which undergo little metabolism
until excretion such as EpiT or metabolites derived from
early stages in metabolism such as PD or 16EN show
enriched values, whereas ongoing metabolism seems to
introduce depleted hydrogen into the steroid backbone,
resulting in more depleted values for later metabolites [80].
This depleted hydrogen is derived from NADPH, which has
low δ2H values. So each introduction of a hydrogen atom
into the steroidal backbone is assumed to result in more
depleted δ2H values of the complete steroid.
Owing to the limited data presently available, it is not
possible to draw a definitive conclusion on the influence of
metabolism on HIR and on the different isotope ratios at
different production sites. The same holds true for the
difference found between glucuronidated and sulfated
steroids.
Influence of urine degradation
Recently, the first investigations on the impact of urinary
degradation on CIR were completed [84]. In contrast to the
common opinion, a strong influence on unconjugated
steroids was found especially at the beginning of the
degradation process. The metabolite of DHEA_S formed
in urine, DCM, showed a very strong influence in its CIR.
Owing to the large pool size of glucuronidated steroids in
urine, these did not reflect any changes in CIR. This finding
is important for doping controls as it supports the use of
IRMS of glucuronidated steroids even if samples show
early signs of degradation.
Further factors influencing CIR of steroids
Ethnicity as an influencing factor has been investigated
several times [55, 56, 76]. Until now, no proof could be
given that ethnicity influences δ13C or Δ values in any way.
One study found a significant influence of exercise
frequencies on the CIR of different steroids [71], a finding
not reflected by subsequent studies [72, 79, 83].
Method validation in IRMS
The validation of IRMS methods is complicated and
depends strongly on the analyte of interest and the sample
preparation used. Therefore, here we again focus only on
steroid measurements in the context of doping controls.
First, several fundamentals of GC/C/IRMS will be dis-
cussed, revealing the main pitfalls for valid measurements.
Then, the application of these fundamentals to doping
control methods as described in the literature will be
summarized.
Fig. 9 Box plots of CIR of DHEA excreted glucuronidated
(DHEA_G) and sulfo-conjugated (DHEA_S). The RefPop encom-
passed n=67 subjects [83]. The difference between the mean values
was found to be highly significant with p<0.001 (t test)
Fig. 8 δ2H values against the δ13C values of a RefPop of n=18 males
[80]. Open diamond EpiT, black diamond PD, square 16EN, diamond
T, open circle DHEA, triangle 5a, black circle OHA, grey circle
11KETO. The error bars represent one standard deviation
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Factors influencing GC/C/IRMS determinations
Since its invention, GC/C/IRMS has been investigated to
prevent possible sources of problems, which may invalidate
the isotope ratio determinations [24, 111]. In 1994, the first
review on “Factors controlling precision and accuracy…”
was published, dealing with problems of non-linearity,
necessary sample sizes and instrument drift over time [112].
At the same time, an investigation on possible isotopic
fractionation during HPLC fractionation was published
[113]. In 1996, a comprehensive investigation of GC
parameters such as GC temperature gradient, gas flow or
split/splitless injection and their possible influence on CIR
was published [114]. As these parameters can change the
measured CIR to a small but significant extent, the authors
suggested some rules for GC/C/IRMS determinations, and
these still hold, such as the use of splitless injections and
validating any changes to a method. In 1998, the influence
of water background was carefully investigated and
demonstrated the necessity of water removal for valid
IRMS determinations [115]. One year later, a comprehen-
sive review of isotopic fractionation for a variety of
chromatographic separations was published [116]. In
2003, Schmitt et al. [117] investigated the extent of the
dependency of CIR under different conditions in the split/
splitless injector. To deal with the same issue of linearity,
recent careful investigations were performed with parame-
ters such as the open split, the GC column and absorption
and desorption in the ion source [118]. Some of the
proposals from this work, such as the addition of carbon
monoxide to reduce effects of non-linearity in the ion
source, may be of interest for doping analysis especially for
that involving low levels of target analytes.
Referring to all these investigations, there are numerous
factors with the potential to affect IRMS measurements.
During sample preparation, losses of analyte can be
accompanied by isotopic fractionation. For steroids, no
fractionation during SPE or LLE has been reported.
However, isotopic fractionation during both hydrolysis of
conjugates and inappropriate HPLC fractionation can occur
[84, 113]. The sample transfer on column, the combustion
process, the open split and the set-up/condition of the ion
source may cause problems.
All these factors have to be under control for valid IRMS
measurements. So it is not surprising that, from the
beginning, scientists working in the field of sports drug
testing have taken care to validate their IRMS methods and
to search for factors influencing isotope values.
Approaches for validation of IRMS methods
To achieve good chromatography of all analytes, adequate
clean-up during sample preparation is a prerequisite;
therefore, preparation methods have always been compli-
cated. The first investigations on possible isotope fraction-
ation during SPE were performed in 1999 [50]. One year
earlier, HPLC clean-up and chromatographic separation of
E and A had been investigated, showing the strong
influence HPLC can have on isotopic values by incomplete
separation of analytes [119]. In 2000, the validation of an
IRMS method was presented, including values for interday
and intraday precision and the use of Shewhart charts was
introduced to IRMS [52]. The use of these charts has been
recommended to monitor method and system stability over
time and to reveal possible drifts of the IRMS instrument
[19, 51, 120].
The approaches described so far for validation only
cover repeatability and reproducibility but could not
show if isotopic fractionation was occurring during
sample preparation. Therefore, in 2004, a validation
procedure was published using child urine fortified with
standards. These fortified urine samples were extracted
and the δ13C values obtained were compared with the
values of the standards used for fortification [58]. A
comparable approach was used to check for isotopic
fractionation during sample preparation of steroids not
regularly found in urine such NORA and BO or
degradation products [65, 82, 84]. It was possible to show
that no significant changes in CIR were introduced by
different sample preparation procedures.
A progressive approach was presented in 2008 and
applied several times afterwards using linear mixing models
to reveal isotopic fractionation during sample preparation
[72, 79, 80, 83, 84, 110]. Repeated fortification of a blank
urine sample with defined amounts of steroid standards
allows both the detection of possible changes in isotopic
values and the repeatability and reproducibility to be tested.
Until 2008, only three RefPops had been investigated
[52, 56, 62], but then the number of publications on
RefPops and population-based reference limits increased
considerably [71, 72, 75, 76, 79, 83]. A RefPop established
according to the common rules constitutes an interesting
and powerful tool for validation. The rules composing a
suitable population have been published by the International
Federation of Clinical Chemistry [121–126]. The calculated
mean values and their SDs include all potential variations
which may occur during sample preparation and measure-
ment. The interindividual variances, which accompany
biological parameters, are also covered by reference limits
derived from a population.
Thus, it is possible to validate a method by establishing
population-derived limits as these encompass all the
expected variations and include them in the calculated
reference limits. Presumably, this approach will be used to
distinguish between endogenous or exogenous sources of
urinary steroids.
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Once established, reference limits can be maintained
even after some parts of the method have been changed if
the new method is compared with the old one. This has
been demonstrated by Saudan et al. [73] using Bland–
Altman plots [127] to estimate the differences between two
sample preparation methods. So, it is not always necessary
to investigate a new RefPop after some parts of a method
have been adopted, as long as the new approach is
compared with the former one and no significant difference
between both approaches is found.
Another important issue to ensure comparability of
measured δ13C values is the calibration of the instrument
with continued traceability of experimental values to the
international standard VPDB. Different methods of cali-
bration are possible; the one mostly supported by isotope
chemists is the principal of identical treatment of the
standard and the analyte [128]. This means that the
standard used for calibration should be chemically similar
to the analyte investigated. Several steroids are commer-
cially available for this purpose, and since 2009 steroid
standards have been prepared especially for doping control
laboratories [129].
Conclusion
Since its first introduction to sports drug testing in 1994,
GC/C/IRMS and associated sample preparation methods
have been carefully improved and laboriously investigated.
Most of the approaches affecting doping control analysis
have been mentioned and discussed within this article.
Especially in recent years, the number of steroids investi-
gated has grown considerably, proving the importance of
GC/C/IRMS in doping controls.
The first attempts made on hydrogen have been
presented but there is ongoing research on this special
topic, which may soon lead to improvements for doping
control. To elucidate the merit of HIR, reference-based
values have to be established and factors influencing HIR
of endogenous steroids have to be investigated and
identified.
Many known factors influencing the CIR of urinary
steroids have been investigated and the impact of these
influences on doping control has been studied. Intensive
and further research may solve still unanswered questions.
As results obtained in sports drug testing always have to
be able to be justified at hearings, validation of IRMS
methods is emphasised and improved continually. The use
of reference-based values to distinguish between endoge-
nous and exogenous isotope ratios will be a promising
approach.
Both isotope ratios of carbon and hydrogen are a highly
interesting research field, providing a powerful tool in the
fight against doping, which will presumably be expanded to
substances other than steroids soon.
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